Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPAR[alpha] agonist

BACKGROUND AND PURPOSE Adipose triglyceride lipase (ATGL) has been identified as a rate-limiting enzyme of mammalian triglyceride catabolism. Deletion of the ATGL gene in mice results in severe lipid accumulation in a variety of tissues including the heart. In the present study we investigated cardi...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 2012-01, Vol.165 (2), p.380
Main Authors: Wolkart, G, Schrammel, A, Dorffel, K, Haemmerle, G, Zechner, R, Mayer, B
Format: Article
Language:English
Subjects:
Medical research
Rodents
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND AND PURPOSE Adipose triglyceride lipase (ATGL) has been identified as a rate-limiting enzyme of mammalian triglyceride catabolism. Deletion of the ATGL gene in mice results in severe lipid accumulation in a variety of tissues including the heart. In the present study we investigated cardiac function in ATGL-deficient mice and the potential therapeutic effects of the PPAR[alpha] and [gamma] agonists Wy14,643 and rosiglitazone, respectively. EXPERIMENTAL APPROACH Hearts isolated from wild-type (WT) mice and ATGL(-/-) mice treated with Wy14,643 (PPAR[alpha] agonist), rosiglitazone (PPAR[gamma] agonist) or vehicle were perfused at a constant flow using the Langendorff technique. Left ventricular (LV) pressure-volume relationships were established, and the response to adrenergic stimulation was determined with noradrenaline (NA). KEY RESULTS Hearts from ATGL(-/-) mice generated higher LV end-diastolic pressure and lower LV developed pressure as a function of intracardiac balloon volume compared to those from WT mice. Likewise, passive wall stress was increased and active wall stress decreased in ATGL(-/-) hearts. Contractile and microvascular responses to NA were substantially reduced in ATGL(-/-) hearts. Cardiac contractility was improved by treating ATGL(-/-) mice with the PPAR[alpha] agonist Wy14,643 but not with the PPAR[gamma] agonist rosiglitazone. CONCLUSIONS AND IMPLICATIONS Our results indicate that lipid accumulation in mouse hearts caused by ATGL gene deletion severely affects systolic and diastolic function, as well as the response to adrenergic stimulation. The beneficial effects of Wy14,643 suggest that the cardiac phenotype of these mice is partially due to impaired PPAR[alpha] signalling. [PUBLICATION ABSTRACT]
ISSN:0007-1188
1476-5381
DOI:10.1111/j.1476-5381.2011.01490.x